Stock Report

Sharon Bio-Medicine Ltd Q2FY22 net profit at Rs. 4.47 crore



Posted On : 2021-11-06 16:12:50( TIMEZONE : IST )

Sharon Bio-Medicine Ltd Q2FY22 net profit at Rs. 4.47 crore

has reported Standalone financial results for the period ended September 30, 2021.

Financial Results (Q2 FY2022) - QoQ Comparison

The company has reported total income of Rs. 45.8498 crores during the period ended September 30, 2021 as compared to Rs. 49.5439 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs. 4.4769 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 4.4942 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. 7.78 for the period ended September 30, 2021 as compared to Rs. 7.81 for the period ended June 30, 2021.

Financials Q2 FY2022 Q1 FY2022 % Change
Total Income ₹ 45.8498 crs ₹49.5439 crs Up Tick / Down Tick-7.46%
Net Profit ₹4.4769 crs ₹4.4942 crs Up Tick / Down Tick-0.38%
EPS ₹7.78 ₹7.81 Up Tick / Down Tick-0.38%

Financial Results (Q2 FY2022) - YoY Comparison

The company has reported total income of Rs. 45.8498 crores during the period ended September 30, 2021 as compared to Rs.43.8951 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.4.4769 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.2.3743 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.7.78 for the period ended September 30, 2021 as compared to Rs.0.20 for the period ended September 30, 2020.

Financials Q2 FY2022 Q2 FY2021 % Change
Total Income ₹ 45.8498 crs ₹43.8951 crs Up Tick / Down Tick4.45%
Net Profit ₹4.4769 crs ₹2.3743 crs Up Tick / Down Tick88.56%
EPS ₹7.78 ₹0.20 Up Tick / Down Tick3,790.00%

Financial Results (Half Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.95.3937 crores during the 6 Months period ended September 30, 2021 as compared to Rs.80.0725 crores during the 6 Months period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.8.9711 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.3.8736 crores for the 6 Months period ended September 30, 2020.

The company has reported EPS of Rs.0.75 for the 6 Months period ended September 30, 2021 as compared to Rs.0.33 for the 6 Months period ended September 30, 2020.

Financials Half Year Ended FY2022 Half Year Ended FY2021 % Change
Total Income ₹95.3937 crs ₹80.0725 crs Up Tick / Down Tick19.13%
Net Profit ₹8.9711 crs ₹3.8736 crs Up Tick / Down Tick131.60%
EPS ₹0.75 ₹0.33 Up Tick / Down Tick127.27%

Source : Equity Bulls

Keywords

SharonBioMedicine Q2FY22 H1FY22 ResultUpdate